UCB has entered into a global co-development and co-commercialization agreement with Novartis covering UCB0599, a potential first in class, small molecule, alpha-synuclein misfolding inhibitor currently in Phase 2 clinical...

View the Online Magazine

Launches

Beckman Coulter’s new urinalysis solution improves laboratory workflow, reduces manual microscopy review to less than 3% and cuts sample processing time by up to...

Beckman Coulter today announced the European launch of the DxU Iris Workcell, a fully-automated system that streamlines urinalysis workflow and reduces manual microscopy. A routine...

New website launches Tower Cold Chain’s global brand identity

Pharmaceutical thermal protection specialist Tower Cold Chain has launched a new brand identity, supported by a new website that provides an enhanced experience for...

Entia rases £12m to launch virtual oncology solution

Med tech business, Entia, has raised $12 million in a funding round to launch a virtual oncology solution. Entia Library will allow patients to perform...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Envirotainer launches CryoSure® – a revolution in -70ºC cryogenic shipping

Envirotainer, the global market leader in secure cold chain solutions for intercontinental shipments of pharmaceuticals, is launching the CryoSure® platform today. This -70oC solution,...

Timestrip introduces new vaccine temperature indicator

Timestrip®, the developer of smart indicator technology, has introduced a new temperature indicator that helps healthcare professionals avoid wastage of vaccines.  Travelling with packs...

Humanigen signs contract with Clinigen for Lenzilumab Managed Access Program in Europe

Humanigen, a Californian clinical-stage biopharma company focused on preventing and treating an immune hyper-response called ‘cytokine storm’, has entered into an arrangement with Clinigen...

GSK to supply Canada with 10,000 doses of COVID vaccine

GSK has signed an agreement with the Government of Canada to supply 10,000 doses of Sotrovimab for injection, a COVID-19 monoclonal antibody therapy developed...

Approvals

MHRA approves COVID-19 treatment found to cut hospitalisation and death by 79%

Another COVID-19 treatment, Xevudy (sotrovimab), has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to be safe...

FDA approves first treatment for common type of post-transplant infection that is resistant to other drugs

The U.S. Food and Drug Administration has approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12 years of age...

Manufacturiung

Finance

Research & Development
Latest

UCB partners with Novartis for Parkinson’s treatments

UCB has entered into a global co-development and co-commercialization agreement with Novartis covering UCB0599, a potential first in class, small molecule, alpha-synuclein misfolding inhibitor...

Nykode Therapeutics to collaborate with Regeneron to develop vaccines against cancer and infectious diseases

Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, has entered into a license and collaboration agreement...

£1.2m project to improve global availability of microneedle drug delivery technology

Microneedles are considered more effective at delivering certain drugs than traditional intravenous injections or oral methods, but they are not widely used. Lack of commercialisation...

New approach provides potential vaccine and treatment for Alzheimer’s

A promising new approach to potentially treat Alzheimer’s disease – and also vaccinate against it – has been developed by a team of UK...

Kala Pharmaceuticals snaps up developer of regenerative biotherapies

Kala Pharmaceuticals, a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, has acquired Combangio,...

Appointments